Abstract
In a recent study, we showed that long-term treatment with two different moisturizers affected TEWL in opposite directions. Therefore, we decided to examine the effect of these moisturizers on the cellular and molecular level. In a randomized controlled study on 20 volunteers, epidermal mRNA expression of genes essential for keratinocyte differentiation and desquamation after a 7-week treatment with two moisturizers was analyzed. Treatment with one test moisturizer increased gene expression of involucrin, transglutaminase 1, kallikrein 5, and kallikrein 7, while the other moisturizer affected only expression of cyclin-dependent kinase inhibitor 1A. Thus, moisturizers are able to modify the skin barrier function and change the mRNA expression of certain epidermal genes. Since the type of influence depends on the composition of the moisturizer, these should be tailored in accordance with the requirement of the barrier of each individual patient, which merits further investigations.
Similar content being viewed by others
Abbreviations
- IVL:
-
Involucrin
- TGM1:
-
Transglutaminase 1
- FLG:
-
Profilaggrin
- CDKN1A:
-
Cyclin-dependent kinase inhibitor 1A
- KLK5:
-
Kallikrein 5 (stratum corneum tryptic enzyme)
- KLK7:
-
Kallikrein 7 (stratum corneum chymotryptic enzyme)
- IL1A:
-
Interleukin-1α
- ACTB:
-
β-actin
- TEWL:
-
Transepidermal water loss
- SLS:
-
Sodium lauryl sulfate
- mRNA:
-
Messenger RNA
- QRT-PCR:
-
Quantitative real-time polymerase chain reaction
- RT:
-
Reverse transcription
- PBS:
-
Phosphate-buffered saline
- DAPI:
-
4′-6-diamidino-2-phenylindole
References
Andersson AC, Lindberg M, Lodén M (1999) The effect of two urea-containing creams on dry, eczemateous skin of atopic patients. I: expert, patient and instrumental evaluation. J Dermatol Treat 10:165–169
Bergstresser PR, Taylor JR (1977) Epidermal ‘turnover time’—a new examination. Br J Dermatol 96:503–509
Buraczewska I, Lodén M (2005) Treatment of surfactant-damaged skin in humans with creams of different pH values. Pharmacology 73:1–7
Buraczewska I, Berne B, Lindberg M et al (2007) Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 156:492–498
Buraczewska I, Broström U, Lodén M (2007) Artificial reduction in transepidermal water loss improves skin barrier function. Br J Dermatol 157:82–86
Chang BD, Watanabe K, Broude EV et al (2000) Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 97:4291–4296
Ekholm E, Egelrud T (1999) Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 291:195–200
Ekholm IE, Brattsand M, Egelrud T (2000) Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 114:56–63
Ghadially R, Halkier-Sorensen L, Elias PM (1992) Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 26:387–396
Hagemann I, Proksch E (1996) Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol 76:353–356
Held E, Sveinsdottir S, Agner T (1999) Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 79:49–51
Held E, Agner T (2001) Effect of moisturizers on skin susceptibility to irritants. Acta Derm Venereol 81:104–107
Hellgren L, Larsson K (1974) On the effect of urea on human epidermis. Dermatologica 149:289–293
Lewis-Jones S, Mugglestone MA (2007) Management of atopic eczema in children aged up to 12 years: summary of NICE guidance. BMJ 335:1263–1264
Lodén M, Olsson H, Axell T et al (1992) Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin. Br J Dermatol 126:137–141
Lodén M, Boström P, Kneczke M (1995) Distribution and keratolytic effect of salicylic acid and urea in human skin. Skin Pharmacol 8:173–178
Lodén M (1996) Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 288:103–107
Lodén M (1997) Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 36:256–260
Lodén M, Andersson AC, Lindberg M (1999) Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 140:264–267
Lodén M, Barany E, Wessman C (2004) The influence of urea treatment on skin susceptibility to surfactant-induced irritation: a placebo-controlled and randomized study. Exogen Dermatol 3:1–6
Man MQ, Feingold KR, Elias PM (1993) Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 129:728–738
Mao-Qiang M, Brown BE, Wu-Pong S et al (1995) Exogenous nonphysiologic vs physiologic lipids: divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 131:809–816
Nemes Z, Marekov LN, Fesus L et al (1999) A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci USA 96:8402–8407
Norlén L (2003) Molecular skin barrier models and some central problems for the understanding of skin barrier structure and function. Skin Pharmacol Appl Skin Physiol 16:203–211
Palmer CN, Irvine AD, Terron-Kwiatkowski A et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441–446
Pilgram GS, Vissers DC, van der Meulen H et al (2001) Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 117:710–717
Sandilands A, O’Regan GM, Liao H et al (2006) Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 126:1770–1775
Seguchi T, Cui CY, Kusuda S et al (1996) Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 288:442–446
Törmä H, Geijer S, Gester T et al (2006) Variations in the mRNA expression of inflammatory mediators, markers of differentiation and lipid-metabolizing enzymes caused by sodium lauryl sulphate in cultured human keratinocytes. Toxicol In Vitro 20:472–479
Törmä H, Lindberg M, Berne B (2008) Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 128:1212–1219
Weinberg WC, Denning MF (2002) P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13:453–464
Weinstein GD, McCullough JL, Ross P (1984) Cell proliferation in normal epidermis. J Invest Dermatol 82:623–628
Wertz PW, Downing DT (1990) Metabolism of topically applied fatty acid methyl esters in BALB/C mouse epidermis. J Dermatol Sci 1:33–37
Zachariae C, Held E, Johansen JD et al (2003) Effect of a moisturizer on skin susceptibility to NiCl2. Acta Derm Venereol 83:93–97
Acknowledgments
This study was financially supported by ACO HUD NORDIC AB, Stockholm and Uppsala University, Uppsala, Sweden and the Welander and Finsen Foundation. We would like to thank Inger Pihl-Lundin, Uppsala University, for technical assistance.
Conflict of interest statement
Buraczewska I. and Lodén M. are employed by ACO HUD NORDIC AB, Stockholm, Sweden, which sponsored the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buraczewska, I., Berne, B., Lindberg, M. et al. Long-term treatment with moisturizers affects the mRNA levels of genes involved in keratinocyte differentiation and desquamation. Arch Dermatol Res 301, 175–181 (2009). https://doi.org/10.1007/s00403-008-0906-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-008-0906-6